Français, , 40kb
Cette note, extraite du chapitre 2 de Réformes économiques: Objectif croissance 2007, contient des informations sur les progrès réalisés dans la mise en œuvre des réformes de politique structurelle identifiées en 2006 pour le Japon.
English, , 38kb
This note, taken from Chapter 2 of Economic Policy Reforms: Going for Growth 2007, contains information about the progress in implementing reforms in line with the 2006 priorities for Japan.
"Competitive Regional Clusters: National Policy Approaches" analyses the objectives, targeting, instruments and inter-governmental role sharing used by 26 programmes in 14 OECD countries.
The theme of the conference was “The recent moves on e-Learning and OER in OECD and Japan”.
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
Le Projet de l'avenir de l'OCDE sur les politiques de gestion des risques a pour mission d'assister les pays de l'OCDE dans l'identification des principales difficultés de la gestion des risques au 21ème siècle, et dans la recherche de solutions.
English, , 2,245kb
Floods and flood-related disasters, such as landslides, are a traditional and serious risk in Japan. In the 1940s and 50s, after flood disasters took thousands of lives, the creation of a comprehensive flood risk management programme led to a dramatic reduction in human casualties.
This site contains a list of key references on Japan. The documentary database includes documents on partnership and local governance that have been published by governments, universities and other organisations.
English, , 1,654kb
This Country Background Report for Japan was prepared by the Higher Education Bureau of the Ministry of Education, Culture, Sports, Science and Technology as an input to the OECD Thematic review of Tertiary Education.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.